Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A21848 | 25003670 | Turk J Gastroenterol | Nonalcoholic fatty liver disease: diagnosis, pathogenesis, and management. | 2014 | Details |
| A21879 | 24983359 | PLoS One | L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway. | 2014 | Details |
| A21887 | 24976715 | World J Gastroenterol | Role of endoscopy in the bariatric surgery of patients. | 2014 | Details |
| A21896 | 24975216 | J Nutr Sci Vitaminol (Tokyo) | Retinol status and expression of retinol-related proteins in methionine-choline deficient rats. | 2014 | Details |
| A21912 | 24966608 | World J Gastroenterol | Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. | 2014 | Details |
| A21937 | 24952996 | Neurogastroenterol Motil | Damage to enteric neurons occurs in mice that develop fatty liver disease but not diabetes in response to a high-fat diet. | 2014 | Details |
| A21962 | 24928925 | BMJ Case Rep | Phytobezoar leading to gastric outlet obstruction in a patient with diabetes. | 2014 | Details |
| A22007 | 24895809 | Hepatogastroenterology | Expression of intestinal tight junction proteins in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22009 | 24894597 | J Dig Dis | Observations on the epidemiology of gastrointestinal and liver cancers in the Asia-Pacific region. | 2014 | Details |
| A22031 | 24865256 | Dig Dis Sci | Tauroursodeoxycholic acid attenuates progression of steatohepatitis in mice fed a methionine-choline-deficient diet. | 2014 | Details |
| A22057 | 24848256 | Sci Transl Med | The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. | 2014 | Details |
| A22086 | 24829701 | Middle East J Dig Dis | Oral Nitrate Reductase Activity Is Not Associated with Development of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Pilot Study. | 2014 | Details |
| A22088 | 24829682 | Middle East J Dig Dis | Probiotics and Nonalcoholic Fatty liver Disease. | 2013 | Details |
| A22102 | 24819989 | Steroids | Bile acids are nutrient signaling hormones. | 2014 | Details |
| A22106 | 24816727 | J Physiol Biochem | Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion. | 2014 | Details |
| A22107 | 24816278 | PLoS One | Lactoferrin dampens high-fructose corn syrup-induced hepatic manifestations of the metabolic syndrome in a murine model. | 2014 | Details |
| A22109 | 24815326 | Clin Gastroenterol Hepatol | The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A22114 | 24811405 | Appl Microbiol Biotechnol | Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice. | 2014 | Details |
| A22136 | 24795254 | Lancet Diabetes Endocrinol | Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial. | 2014 | Details |
| A22151 | 24786095 | Int J Mol Sci | Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). | 2014 | Details |
| A22164 | 24775330 | BMC Gastroenterol | Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan. | 2014 | Details |
| A22165 | 24775093 | J Nutr Biochem | Diets enriched in trans-11 vaccenic acid alleviate ectopic lipid accumulation in a rat model of NAFLD and metabolic syndrome. | 2014 | Details |
| A22262 | 24708895 | Br J Nutr | Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice. | 2014 | Details |
| A22335 | 24652102 | J Gastroenterol | The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. | 2014 | Details |
| A22376 | 24631029 | Dig Liver Dis | Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity. | 2014 | Details |
| A22386 | 24627311 | Drug Saf | Potential approaches to ameliorate hepatic fat accumulation seen with MTP inhibition. | 2014 | Details |
| A22413 | 24604038 | Indian J Med Res | Probiotic foods: can their increasing use in India ameliorate the burden of chronic lifestyle disorders? | 2014 | Details |
| A22429 | 24587650 | World J Gastroenterol | Clinical approaches to non-alcoholic fatty liver disease. | 2014 | Details |
| A22432 | 24582567 | Clin Gastroenterol Hepatol | Resveratrol does not benefit patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A22433 | 24581591 | Clin Res Hepatol Gastroenterol | Non-cirrhotic portal hypertension--concept, diagnosis and clinical management. | 2014 | Details |
| A22468 | 24547986 | J Gastroenterol Hepatol | Gut microbiota and liver disease. | 2014 | Details |
| A22470 | 24535283 | Curr Opin Lipidol | Regulation of bile acid homeostasis by the intestinal Diet1-FGF15/19 axis. | 2014 | Details |
| A22475 | 24530600 | Clin Gastroenterol Hepatol | Lack of efficacy of an inhibitor of PDE4 in phase 1 and 2 trials of patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A22519 | 24495527 | Proc Nutr Soc | 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk. | 2014 | Details |
| A22528 | 24489924 | PLoS One | Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22531 | 24488902 | Eur Rev Med Pharmacol Sci | Efficacy of Tiopronin in treatment of severe non-alcoholic fatty liver disease. | 2014 | Details |
| A22546 | 24475018 | PLoS One | Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. | 2014 | Details |
| A22590 | 24440671 | Gastroenterology | Interactions between the intestinal microbiome and liver diseases. | 2014 | Details |
| A22591 | 24438438 | BMC Public Health | Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men--the role of gut microbiota composition: study protocol for the AELC randomized controlled trial. | 2014 | Details |
| A22610 | 24417071 | Klin Med (Mosk) | [Obesity and diseases of digestive organs]. | 2013 | Details |
| A22623 | 24402126 | Int J Mol Sci | Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications. | 2014 | Details |
| A22688 | 25911912 | Eksp Klin Gastroenterol | [Characteristics of the gastrointestinal myoelectrical activity in patients with nonalcoholic fatty liver disease associated with metabolic syndrome]. | 2014 | Details |
| A22712 | 24363521 | World J Gastroenterol | Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders. | 2013 | Details |
| A22731 | 24351080 | Liver Int | Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22734 | 24348640 | Hepat Mon | The Relationship between Intestinal Motility and Interstitial Cells of Cajal in Nonalcoholic Fatty Liver Mice. | 2013 | Details |
| A22743 | 24337650 | Semin Immunopathol | Microbiota and nonalcoholic steatohepatitis. | 2013 | Details |
| A22770 | 24321090 | BMC Gastroenterol | Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice. | 2013 | Details |
| A22778 | 24314869 | J Nutr Biochem | Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet. | 2013 | Details |
| A22789 | 24303464 | World J Clin Cases | Liver failure in an obese middle-aged woman after biliointestinal bypass. | 2013 | Details |
| A22807 | 24290319 | Rev Gastroenterol Mex | [Gut microbiota in health and disease]. | 2013 | Details |
| A22811 | 26202294 | Hepatol Int | An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis. | 2013 | Details |
| A22847 | 24274865 | Clin Liver Dis | Obesity and NAFLD: the role of bacteria and microbiota. | 2013 | Details |
| A22849 | 24274862 | Clin Liver Dis | Obesity-associated nonalcoholic fatty liver disease. | 2013 | Details |
| A22850 | 24274861 | Clin Liver Dis | Obesity and liver disease: the epidemic of the twenty-first century. | 2014 | Details |
| A22858 | 24251704 | J Gastroenterol Hepatol | Obesity and gastrointestinal liver disorders in Japan. | 2013 | Details |
| A22859 | 24251697 | J Gastroenterol Hepatol | Role of the gut microbiota in human nutrition and metabolism. | 2013 | Details |
| A22869 | 24265237 | Compr Physiol | Steatosis in the liver. | 2013 | Details |
| A22878 | 24259964 | World J Gastroenterol | Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. | 2013 | Details |
| A22890 | 24249968 | J Clin Biochem Nutr | Dmbt1 does not affect a Western style diet-induced liver damage in mice. | 2013 | Details |
| A22898 | 24226095 | J Biol Chem | Retinoic acid-related orphan receptor α regulates diurnal rhythm and fasting induction of sterol 12α-hydroxylase in bile acid synthesis. | 2013 | Details |
| A22902 | 24222944 | World J Gastroenterol | Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. | 2013 | Details |
| A22906 | 24222092 | Semin Liver Dis | The role of gastrointestinal hormones in hepatic lipid metabolism. | 2013 | Details |
| A22926 | 24205731 | Nihon Rinsho | [An inhibitor of intestinal cholesterol transporter]. | 2013 | Details |
| A22932 | 24196453 | Semin Immunopathol | Gut microbiome and metabolic diseases. | 2013 | Details |
| A22991 | 24132155 | Int J Mol Sci | Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). | 2013 | Details |
| A23020 | 24113768 | Am J Physiol Gastrointest Liver Physiol | Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model. | 2013 | Details |
| A23053 | 24075647 | J Autoimmun | Role of the intestinal microbiome in liver disease. | 2013 | Details |
| A23055 | 24074713 | Zhonghua Gan Zang Bing Za Zhi | [Aspartate-ornithine granules in the treatment of nonalcoholic steatohepatitis: a multiple-dose parallel controlled clinical trial]. | 2013 | Details |
| A23072 | 24065998 | Hepat Mon | Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (NAFLD). | 2013 | Details |
| A23076 | 24064383 | Free Radic Biol Med | CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis. | 2013 | Details |
| A23081 | 24059726 | Mini Rev Med Chem | Hepatic diseases related to triglyceride metabolism. | 2013 | Details |
| A23113 | 24030232 | Dig Dis | Liver complications in inflammatory bowel diseases. | 2013 | Details |
| A23123 | 24023483 | World J Gastroenterol | What does irritable bowel syndrome share with non-alcoholic fatty liver disease? | 2013 | Details |
| A23131 | 24018052 | Gastroenterology | Therapeutic potential of fecal microbiota transplantation. | 2013 | Details |
| A23169 | 23834053 | Nutr Hosp | Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism. | 2013 | Details |
| A23206 | 23959503 | Hepatology | Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice. | 2014 | Details |
| A23208 | 23958600 | Nat Rev Gastroenterol Hepatol | The Gordian Knot of dysbiosis, obesity and NAFLD. | 2013 | Details |
| A23237 | 23932906 | Clin Gastroenterol Hepatol | The impact of network medicine in gastroenterology and hepatology. | 2013 | Details |
| A23277 | 23905917 | J Allergy Clin Immunol | Innate sensors of pathogen and stress: linking inflammation to obesity. | 2013 | Details |
| A23315 | 23855294 | J Gastroenterol Hepatol | Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. | 2013 | Details |
| A23319 | 23873346 | Curr Opin Clin Nutr Metab Care | The gut-liver axis. | 2013 | Details |
| A23324 | 23870449 | BMC Pediatr | Pediatric non alcoholic fatty liver disease: more on novel treatment targets. | 2013 | Details |
| A23376 | 23834389 | Hepatol Res | Augmented hepatic Toll-like receptors by fatty acids trigger the pro-inflammatory state of non-alcoholic fatty liver disease in mice. | 2013 | Details |
| A23386 | 23827477 | Trends Endocrinol Metab | Non-alcoholic steatohepatitis: a microbiota-driven disease. | 2013 | Details |
| A23414 | 23803760 | Nature | Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. | 2013 | Details |
| A23421 | 23798362 | J Hepatobiliary Pancreat Sci | Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy. | 2013 | Details |
| A23447 | 23772273 | World J Diabetes | Gastrointestinal complications of diabetes mellitus. | 2013 | Details |
| A23474 | 23747246 | Cell Metab | Innate immune receptors: key regulators of metabolic disease progression. | 2013 | Details |
| A23476 | 23745619 | Metab Syndr Relat Disord | Nonalcoholic fatty liver disease and reduced serum vitamin D(3) levels. | 2013 | Details |
| A23481 | 23742138 | J Agric Food Chem | Altered hepatic gene expression profiles associated with improved fatty liver, insulin resistance, and intestinal permeability after hydroxypropyl methylcellulose (HPMC) supplementation in diet-induced obese mice. | 2013 | Details |
| A23484 | 23739675 | Int J Mol Sci | In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A23492 | 23731881 | Best Pract Res Clin Endocrinol Metab | Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae. | 2013 | Details |
| A23510 | 25755488 | J Clin Exp Hepatol | Gut-liver axis: role of inflammasomes. | 2013 | Details |
| A23519 | 23715726 | Am J Physiol Endocrinol Metab | Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet. | 2013 | Details |
| A23528 | 23705529 | Adolesc Med State Art Rev | Update in adolescent gastroenterology. | 2013 | Details |
| A23542 | 23696823 | PLoS One | Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis. | 2013 | Details |
| A23547 | 23692125 | Free Radic Res | A high-fat and cholesterol diet causes fatty liver in guinea pigs. The role of iron and oxidative damage. | 2013 | Details |
| A23625 | 23619251 | Ann Hepatol | Probiotics in non-alcoholic fatty liver disease: which and when. | 2013 | Details |
| A23632 | 23611286 | Adv Immunol | The intestinal microbiota in chronic liver disease. | 2013 | Details |
| A23709 | 23548197 | J Hepatol | Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats. | 2013 | Details |